Here we highlight 2 small cap stocks with Zacks’ Outperform ratings that pulled back despite recent quarterly announcements which were arguably strong but a bit noisy.Elite Pharmaceuticals Inc. (ELTP) is a manufacturer of generic drugs. Its focus on controlled-release products which requires a higher level of manufacturing skill, combined with vertical integration, are key differentiators in what is commonly viewed as a price-sensitive commodity business. These complex formulations include CNS stimulants, a ...